Table 3 Comparison of clinical measurements in patients with glucocorticoid-induced osteoporosis with and without vertebral fractures

Age (years)

45.7 (14.3)

61.8 (13.1)

< 0.0001***

Body mass index

22.12 (4.13)

20.99 (3.86)

0.18

Bone mineral density (g/cm²)

 Lumbar spine

0.89 (0.12)

0.86 (0.148)

0.087

 Femoral neck

0.675 (0.11)

0.589 (0.115)

< 0.0001***

 Total hip

0.78 (0.118)

0.671 (0.11)

< 0.0001***

 Disease duration (years)

13.8 (9.52)

22.4 (10.6)

< 0.0001***

 Disease duration subtracted from age (years)

31.8 (14.4)

39.4 (14.7)

0.0039**

 GC treatment duration (years)

12.1 (10.2)

21.6 (10.4)

< 0.0001***

 Present GC dose (mg)

8.06 (3.51)

8.24 (3.14)

0.57

 Cumulative GC dose (g)

374.1 (347.6)

490.1 (482.6)

0.29